Literature DB >> 16902780

Injection tongueplasty: effects of sclerosant OK-432 on rat tongue.

Gurkan Keskin1, Sinem Keskin, Omer Aydin, Yesim Gurbuz, Emre Ustundag.   

Abstract

Our aim was to investigate the effect of sclerosant agent OK-432 on tongue fibrosis and to determine whether the fibrosis formed by this substance increases with dose. Fifty Wistar albino rats were divided into three groups for the study. In the first group 0.2 ml OK-432, in the second group 0.5 ml OK-432, and in the third group physiological saline as the control substance was injected into the tongue of these rats. Subjects were sacrificed on the first day, first week, first month, third month and sixth month following the injection. Cross-sections of the tongues were stained with hematoxylin-eosin (HE) and Masson Tri-chrome. The degree of fibrosis was measured using ocular micrometry. A significant amount of fibrosis was observed in both the 0.2 ml (P = 0.020) and 0.5 ml (P = 0.003) OK-432 injection groups. OK-432 is a material that causes significant fibrosis in the muscle when compared to physiological saline. The degree of fibrosis in the tongue increases with dose.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16902780     DOI: 10.1007/s00405-006-0136-5

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  20 in total

Review 1.  Tongue neuromuscular and direct hypoglossal nerve stimulation for obstructive sleep apnea.

Authors:  David W Eisele; Alan R Schwartz; Philip L Smith
Journal:  Otolaryngol Clin North Am       Date:  2003-06       Impact factor: 3.346

2.  Acute cardiovascular instability during percutaneous ethanol injection of a hepatocellular carcinoma under general anesthesia.

Authors:  Bhiken Naik; Emilio Lobato; Felipe Urdaneta
Journal:  Anesthesiology       Date:  2004-05       Impact factor: 7.892

3.  Sclerotherapy of reticular and telangiectatic veins of the face, hands, and chest.

Authors:  Leyda E Bowes; Mitchel P Goldman
Journal:  Dermatol Surg       Date:  2002-01       Impact factor: 3.398

4.  Injection snoreplasty: how to treat snoring without all the pain and expense.

Authors:  S E Brietzke; E A Mair
Journal:  Otolaryngol Head Neck Surg       Date:  2001-05       Impact factor: 3.497

5.  Sclerosing of recurrent lymphangioma using OK-432.

Authors:  M Mikhail; R Kennedy; B Cramer; T Smith
Journal:  J Pediatr Surg       Date:  1995-08       Impact factor: 2.545

6.  Clinical experience with lingualplasty as part of the treatment of severe obstructive sleep apnea.

Authors:  B T Woodson; S Fujita
Journal:  Otolaryngol Head Neck Surg       Date:  1992-07       Impact factor: 3.497

7.  Laser-assisted uvulopalatoplasty for obstructive sleep apnea.

Authors:  S A Mickelson
Journal:  Laryngoscope       Date:  1996-01       Impact factor: 3.325

8.  Mandibular advancement and obstructive sleep apnea syndrome.

Authors:  N Powell; C Guilleminault; R Riley; L Smith
Journal:  Bull Eur Physiopathol Respir       Date:  1983 Nov-Dec

9.  Treatment of ranula wth intracystic injection of the streptococcal preparation OK-432.

Authors:  Shigeru Fukase; Nobuo Ohta; Kazutoshi Inamura; Masaru Aoyagi
Journal:  Ann Otol Rhinol Laryngol       Date:  2003-03       Impact factor: 1.547

10.  Radiofrequency volumetric reduction of the palate: An extended follow-up study.

Authors:  K K Li; N B Powell; R W Riley; R J Troell; C Guilleminault
Journal:  Otolaryngol Head Neck Surg       Date:  2000-03       Impact factor: 5.591

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.